Last 12 months
Inside the activity.
13 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 5 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 1 | 5 |
| Apr 2026 | 1 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC |
Yednock TedEVP & Chief Scientific Officer
|
SaleCommon Stock | 16,190 | $20.00 | $323,859.90 |
DisclosureSEC source: 0001567619-21-017166 · doc1.xml · nonDerivative · entry 3 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $20.00 to $20.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC |
Yednock TedEVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 1,190 | $5.11 | $6,080.66 |
DisclosureSEC source: 0001567619-21-017166 · doc1.xml · nonDerivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC |
Yednock TedEVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 15,000 | $1.41 | $21,144.00 |
DisclosureSEC source: 0001567619-21-017166 · doc1.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC |
Lew JenniferEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.49 | $0.00 |
DisclosureSEC source: 0001567619-21-017165 · doc1.xml · derivative · entry 3 Lew Jennifer · CIK 0001465994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,793 Underlying: Common Stock · 3,500 shares Expires 2029-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 3, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC |
Lew JenniferEVP & Chief Financial Officer
|
SaleCommon Stock | 3,500 | $20.01 | $70,033.60 |
DisclosureSEC source: 0001567619-21-017165 · doc1.xml · nonDerivative · entry 2 Lew Jennifer · CIK 0001465994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $20.00 to $20.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC |
Lew JenniferEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 3,500 | $7.49 | $26,209.75 |
DisclosureSEC source: 0001567619-21-017165 · doc1.xml · nonDerivative · entry 1 Lew Jennifer · CIK 0001465994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 21:18 UTC |
Waddill William D.Director
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $19.73 | $0.00 |
DisclosureSEC source: 0001567619-21-015937 · doc1.xml · derivative · entry 1 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-08-12 F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from August 12, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 16:32 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · derivative · entry 6 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,494 Underlying: Common Stock · 3,750 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 16:32 UTC |
Love DouglasDirector · President & CEO
|
SaleCommon Stock | 3,750 | $22.55 | $84,562.50 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · nonDerivative · entry 4 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 16:32 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionCommon Stock | 3,750 | $1.41 | $5,286.00 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · nonDerivative · entry 3 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 16:32 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · derivative · entry 5 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,244 Underlying: Common Stock · 3,750 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 16:32 UTC |
Love DouglasDirector · President & CEO
|
SaleCommon Stock | 3,750 | $22.31 | $83,667.38 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · nonDerivative · entry 2 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $22.02 to $22.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 16:32 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionCommon Stock | 3,750 | $1.41 | $5,286.00 |
DisclosureSEC source: 0001567619-21-011901 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:47 UTC |
Yednock TedEVP & Chief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-011776 · doc1.xml · derivative · entry 4 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,615 Underlying: Common Stock · 15,000 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:47 UTC |
Yednock TedEVP & Chief Scientific Officer
|
SaleCommon Stock | 2,184 | $21.72 | $47,440.85 |
DisclosureSEC source: 0001567619-21-011776 · doc1.xml · nonDerivative · entry 3 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades in prices ranging from $21.665 to $21.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:47 UTC |
Yednock TedEVP & Chief Scientific Officer
|
SaleCommon Stock | 12,816 | $21.45 | $274,883.98 |
DisclosureSEC source: 0001567619-21-011776 · doc1.xml · nonDerivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,184 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $20.67 to $21.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:47 UTC |
Yednock TedEVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 15,000 | $1.41 | $21,144.00 |
DisclosureSEC source: 0001567619-21-011776 · doc1.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 21:12 UTC |
WIGGANS THOMAS GDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001567619-21-011722 · doc1.xml · derivative · entry 1 WIGGANS THOMAS G · CIK 0001208907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 2, 2021 or (ii) the next Annual Meeting following June 2, 2021, subject to Reporting Person's continuous service as a director until such vesting date. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 21:14 UTC |
Satter Muneer ADirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001567619-21-011723 · doc1.xml · derivative · entry 1 Satter Muneer A · CIK 0001315797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 2, 2021 or (ii) the next Annual Meeting following June 2, 2021, subject to Reporting Person's continuous service as a director until such vesting date. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 21:11 UTC |
Choi JungDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001567619-21-011721 · doc1.xml · derivative · entry 1 Choi Jung · CIK 0001650126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 2, 2021 or (ii) the next Annual Meeting following June 2, 2021, subject to Reporting Person's continuous service as a director until such vesting date. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 21:10 UTC |
Carson William H.Director
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001567619-21-011720 · doc1.xml · derivative · entry 1 Carson William H. · CIK 0001824280 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 2, 2021 or (ii) the next Annual Meeting following June 2, 2021, subject to Reporting Person's continuous service as a director until such vesting date. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 21:00 UTC |
Sun RickyDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0000899243-21-022064 · doc4.xml · derivative · entry 1 Sun Ricky · CIK 0001790589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-02 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of June 2, 2021 or (ii) the next Annual Meeting following June 2, 2021, subject to Reporting Person's continuous service as a director until such vesting date. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 22:01 UTC |
Lew JenniferEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $7.49 | $0.00 |
DisclosureSEC source: 0001567619-21-011453 · doc1.xml · derivative · entry 3 Lew Jennifer · CIK 0001465994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,293 Underlying: Common Stock · 3,500 shares Expires 2029-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 3, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 22:01 UTC |
Lew JenniferEVP & Chief Financial Officer
|
SaleCommon Stock | 3,500 | $22.24 | $77,835.10 |
DisclosureSEC source: 0001567619-21-011453 · doc1.xml · nonDerivative · entry 2 Lew Jennifer · CIK 0001465994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $21.78 to $22.67, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 22:01 UTC |
Lew JenniferEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 3,500 | $7.49 | $26,209.75 |
DisclosureSEC source: 0001567619-21-011453 · doc1.xml · nonDerivative · entry 1 Lew Jennifer · CIK 0001465994 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 12:31 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · derivative · entry 7 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,994 Underlying: Common Stock · 500 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 12:31 UTC |
Love DouglasDirector · President & CEO
|
SaleCommon Stock | 300 | $28.01 | $8,403.00 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · nonDerivative · entry 5 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 12:31 UTC |
Love DouglasDirector · President & CEO
|
SaleCommon Stock | 200 | $28.19 | $5,638.00 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · nonDerivative · entry 4 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 12:31 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionCommon Stock | 500 | $1.41 | $704.80 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · nonDerivative · entry 3 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 12:31 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,102 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · derivative · entry 6 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,494 Underlying: Common Stock · 7,102 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 12:31 UTC |
Love DouglasDirector · President & CEO
|
SaleCommon Stock | 7,102 | $28.11 | $199,620.89 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · nonDerivative · entry 2 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $28.00 to $28.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 12:31 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionCommon Stock | 7,102 | $1.41 | $10,010.98 |
DisclosureSEC source: 0001567619-21-007429 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 16:04 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · derivative · entry 9 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,596 Underlying: Common Stock · 3,750 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 16:04 UTC |
Love DouglasDirector · President & CEO
|
SaleCommon Stock | 1,850 | $24.78 | $45,850.96 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 7 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F7 · price: This transaction was executed in multiple trades in prices ranging from $24.63 to $25.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 16:04 UTC |
Love DouglasDirector · President & CEO
|
SaleCommon Stock | 1,900 | $24.27 | $46,115.09 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 6 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,850 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F6 · price: This transaction was executed in multiple trades in prices ranging from $23.63 to $24.56, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 30, 2021 Filed Mar 31, 2021 16:04 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionCommon Stock | 3,750 | $1.41 | $5,286.00 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 5 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · derivative · entry 8 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,346 Underlying: Common Stock · 3,750 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC |
Love DouglasDirector · President & CEO
|
SaleCommon Stock | 300 | $27.24 | $8,171.49 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 4 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades in prices ranging from $27.03 to $27.515, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC |
Love DouglasDirector · President & CEO
|
SaleCommon Stock | 600 | $26.42 | $15,851.04 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 3 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades in prices ranging from $26.02 to $27.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC |
Love DouglasDirector · President & CEO
|
SaleCommon Stock | 2,850 | $25.02 | $71,311.56 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 2 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $24.74 to $25.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 29, 2021 Filed Mar 31, 2021 16:04 UTC |
Love DouglasDirector · President & CEO
|
Exercise / conversionCommon Stock | 3,750 | $1.41 | $5,286.00 |
DisclosureSEC source: 0001567619-21-007290 · doc1.xml · nonDerivative · entry 1 Love Douglas · CIK 0001818520 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC |
Yednock TedEVP & Chief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,175 | $0.00 Strike: $5.11 | $0.00 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · derivative · entry 7 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,129 Underlying: Common Stock · 1,175 shares Expires 2029-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from December 12, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC |
Yednock TedEVP & Chief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · derivative · entry 6 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,615 Underlying: Common Stock · 15,000 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC |
Yednock TedEVP & Chief Scientific Officer
|
SaleCommon Stock | 237 | $29.96 | $7,100.52 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 5 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC |
Yednock TedEVP & Chief Scientific Officer
|
SaleCommon Stock | 5,680 | $29.21 | $165,913.94 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 4 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades in prices ranging from $28.92 to $29.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC |
Yednock TedEVP & Chief Scientific Officer
|
SaleCommon Stock | 10,258 | $28.54 | $292,755.11 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 3 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,917 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $27.91 to $28.89, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC |
Yednock TedEVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 1,175 | $5.11 | $6,004.02 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC |
Yednock TedEVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 15,000 | $1.41 | $21,144.00 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 21:52 UTC |
Keswani Sanjay ChandruEVP & Chief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,995 | $0.00 Strike: $7.49 | $0.00 |
DisclosureSEC source: 0001567619-21-007084 · doc1.xml · derivative · entry 3 Keswani Sanjay · CIK 0001818524 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,956 Underlying: Common Stock · 3,995 shares Expires 2029-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 17, 2019 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| March 24, 2021 Filed Mar 26, 2021 21:52 UTC |
Keswani Sanjay ChandruEVP & Chief Medical Officer
|
SaleCommon Stock | 3,995 | $30.17 | $120,511.97 |
DisclosureSEC source: 0001567619-21-007084 · doc1.xml · nonDerivative · entry 2 Keswani Sanjay · CIK 0001818524 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $30.00 to $30.49, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.